Analysis of 492 prostate tumor genomes from the TCGA dataset (Fig. 1a) indicated that hemizygous loss of PPP2R2A occurred in ~42% (206/492) of prostate adenocarcinomas (shallow deletion). This evidence concerns the gene PPP2R2A and prostate adenocarcinoma.